24 results
Thumbnail

D2.378 - Evaluations of Safety Margins and Response to Deucrictibant Extended-Release (XR) Tablet in Combination with Deucrictibant Immediate-Release (IR) Capsule

Thumbnail

D2.367 - Hepatic Involvement and Inflammatory Bowel Disease in Chronic Granulomatous Disease: A Retrospective Evaluation

Thumbnail

D2.368 - Concurrent Hereditary Angioedema Type I and Common Variable Immunodeficiency Presenting as Suspected Antibiotic Hypersensitivity: Case Report and Literature Review

Thumbnail

D2.370 - Chronic urticaria and autoimmunity: clinical, laboratory and molecular correlations

Thumbnail

D2.374 - Diagnostic delay in children with primary immunodeficiencies: clinical consequences in a single-country cohort from the Republic of Moldova

Thumbnail

D2.375 - Structural lung changes detected by chest CT in pediatric patients with combined immunodeficiencies

Thumbnail

D2.377 - Severe Eosinophilia as an Atypical Initial Presentation of X-Linked Hyper-IgM Syndrome Due to CD40LG Deficiency

Thumbnail

D3.274 - Feasibility of Digestive Enzyme Supplementation for Cow’s Milk Allergy in Exclusively Breastfed Infants

Thumbnail

D3.271 - Development of a multiplex assay to assess the risk of IgE cross-reactivity to new protein sources

Thumbnail

D3.275 - In silico based assessment of intrinsic protein features for ranking clinical relevance of plant-based food allergens

Thumbnail

D3.277 - Tolerance to canned fish in patients allergic to β -parvalbumins

Thumbnail

D3.278 - Tropomyosin-Driven Cross-Reactivity Between Shellfish and House Dust Mites: A Case Report

Thumbnail

D3.279 - SWEET HONEY AND SOUR ALLERGIES: POLLEN-FOOD DEFENSIN CROSS-REACTIVITY - a case series

Thumbnail

D3.281 - A Challenging Case of Paediatric Potato Allergy with Discordant Diagnostic Findings

Thumbnail

D3.282 - A Case of Nonsteroidal Anti-Inflammatory Drug-Exacerbated Food Allergy

Thumbnail

D3.280 - Severe Anaphylaxis Induced by Turkey Egg with Tolerance to Hen’s Egg and Poultry Meat: A First Report

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria